Novel Formulation of Meloxicam
    6.
    发明申请
    Novel Formulation of Meloxicam 有权
    美洛昔康的新型配方

    公开(公告)号:US20150352122A1

    公开(公告)日:2015-12-10

    申请号:US14675410

    申请日:2015-03-31

    申请人: ICEUTICA PTY LTD.

    发明人: H. William Bosch

    IPC分类号: A61K31/5415 A61K9/14

    摘要: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.

    摘要翻译: 描述了含有5mg或10mg美洛昔康的美洛昔康的单位剂量形式,其提供有效的疼痛缓解并具有所需的药代动力学性质。 当单次剂量给予患者并且可用于治疗疼痛(例如相对低的全身暴露于美洛昔康的骨关节炎疼痛)时,单位剂型可以提供疼痛缓解。

    Novel formulation of meloxicam
    8.
    发明申请

    公开(公告)号:US20210213028A1

    公开(公告)日:2021-07-15

    申请号:US17300136

    申请日:2021-03-18

    申请人: ICEUTICA PTY LTD.

    发明人: H. William Bosch

    摘要: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.

    Novel Formulation of Meloxicam
    9.
    发明申请

    公开(公告)号:US20200085835A1

    公开(公告)日:2020-03-19

    申请号:US16689032

    申请日:2019-11-19

    申请人: ICEUTICA PTY LTD.

    发明人: H. William Bosch

    摘要: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.